Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans

Journal of Physiology and Pharmacology

Volumn 48, Issue 3, 1997, Pages 383-391

  Konturek, J W ^a   Dembinski A ^b   Konturek, S J ^b   Domschke, W ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

Adaptation; Aspirin; Epithelial cell proliferation; Gastric blood flow; Helicobacter pylori; Stomach

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADAPTATION; ADULT; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG BLOOD LEVEL; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; STOMACH; STOMACH BLOOD FLOW; STOMACH INJURY; STOMACH LAVAGE; TABLET;

ADAPTATION, PHYSIOLOGICAL; ADULT; ASPIRIN; DNA; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; SALICYLATES;

EID: 1842407788     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin like drugs. Nature 1971; 231: 232-235.
2. Ivey KJ. Mechanisms of NSAID-induced gastric damage; actions of therapeutic agents. Am J Med 1988; 84: (Suppl 2A), 41-48.
3. Whittle BJR. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1991; 92: 94-98.
4. Konturek SJ, Piastucki I, Brzozowski T, Dembinska-Kiec A, Gryglewski R. Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology 1981; 80: 4-9.
5. Robert A, Nezamis JE, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rats - Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and termal injury. Gastroenterologv 1979; 77: 433-443.
6. Rainford KD, Willis C. Relationship of gastric mucosal damage induced in pigs by antiinflammatory drugs to their effect on prostaglandin production. Dig Dis Sci 1992; 27: 624-635.
7. Eastwood GL, Quimby GF. Effect of chronic aspirin ingestion on epithelial cell proliferation in rat fundus, antrum, and duodenum. Gastroenterology 1982; 82: 852-856.
8. Baumgartner A, Kölz H R, Halter F. Indomethacin and turnover of gastric mucosal cell in the rat. Am J Physiol 1986; 250: G830-G835.
9. Levi S, Goodland RA, Lee CY et al. Inhibitory effect of nonsteroidal antiinflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990; 336: 840-843.
10. Konturek JW, Dembinski A, Stoll R, Domschke W, Konturek SJ. Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth, and neutrophil activation. Gut 1994; 35: 1197-1204.
11. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315.
12. Rollason TP, Stone J, Rhodes JM. Spiral organisms in endoscopie biopsies of the human stomach. J Clin Pathol 1984; 37: 23-26.
13. Konturek PC, Konturek SJ. Role of Helicobacter pylori infection in gastro-duodenal secretion and in pathogenesis of peptic ulcer and gastritis. J Physiol Pharmacol 1994; 45: 333-350.
14. Parsonnet D. Eurogast Study Group. An international association between Helicobacter pylori infestion and gastric cancer. Lancet 1991; 341: 359-362.
15. Watherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577.
16. Walt R, Katchinski B, Logan R, Ashleigh J, Langman MJS. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 1: 489-492.
17. Graham DY, Smith JL, Dobbs SM. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci 1983; 28: 1-6.
18. Graham DY, Lacey Smith JL, Spjut HJ, Torres E. Gastric adaptation. Studies, studies in humans during continuous aspirin administration. Gastroenterology 1988; 95: 327-333.
19. 2 metabolism. Gut 1992; 33: 164-169.
20. Lipscomb GR, Wallis N, Armstrong G, Goodman MJ, Rees WDW. Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man. Dig Dis Sci 1996; 41: 1583-1588.
21. 13C-urea in the diagnosis of Helicobacter pylori infection. J Physiol Pharmacol 1996; 47: 545-558.
22. 2 and ranitidine in prevention of gastric bleeding by aspirin in man. Gut 1981; 24: 89-93.
23. Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprophen, aspirin and other nonsteroidal antiinflammatory agents. Am J Med 1984; 77: 19-24.
24. Ceriotti G. Determination of nucleic acids in animal tissues. J Biol Chem 1955; 214: 59-63.
25. Burton K. A study of the conditions and mechanisms of the diphenylamine reaction for the colorymetric estimation of deoxyribonucleic acid. Biochem J 1956; 62: 315-317.
26. Giles KW, Myers A. An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature 1965; 206: 93-97.
27. Kordecki H, Kurowski M, Pilecka P, Kosik R. What is the influence of Helicobacter pylori infection on mucosal lesions development in patients taking acetylsalicylic acid. Gut 1996; 39: A89.
28. Lee YT, Chan FKL, Sung IY. Prevention of NSAID-induced ulcers by eradication of H. pylori. A prospective randomized study. Gut 1996; 39: A26.
29. Laine L, Cominelli F, Sloane R, Casini-Raggi V, Martin-Sorensen M, Weinstein WM. Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial. Aliment Pharmacol Ther 1995; 9: 127-135.
30. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid biological and therapeutic implications. Gastroenterology 1996; 110: 926-938.